Literature DB >> 3454446

Distinguishing depressive and negative symptoms in chronic schizophrenia.

H A Whiteford1, S J Riney, J G Csernansky.   

Abstract

In rating negative symptoms in chronic schizophrenia the Scale for the Assessment of Negative Symptoms showed less overlap with the Hamilton Rating Scale for Depression than the withdrawal-retardation subscale of the Brief Psychiatric Rating Scale. The distinction between depression and negative symptoms is best made by a careful evaluation of the patients' mood and thoughts.

Entities:  

Mesh:

Year:  1987        PMID: 3454446     DOI: 10.1159/000284506

Source DB:  PubMed          Journal:  Psychopathology        ISSN: 0254-4962            Impact factor:   1.944


  5 in total

Review 1.  Anhedonia in schizophrenia: a review of assessment strategies.

Authors:  William P Horan; Ann M Kring; Jack J Blanchard
Journal:  Schizophr Bull       Date:  2005-10-12       Impact factor: 9.306

2.  Dynamic interplay between life events and course of psychotic disorders: 10-year longitudinal study following first admission.

Authors:  Kayla R Donaldson; Katherine G Jonas; Yuan Tian; Emmett M Larsen; Daniel N Klein; Aprajita Mohanty; Evelyn J Bromet; Roman Kotov
Journal:  Psychol Med       Date:  2020-11-04       Impact factor: 10.592

3.  The Direct and Indirect Effects of Paliperidone Extended-release on Depressive Symptoms in Schizoaffective Disorder: A Path Analysis.

Authors:  Ibrahim Turkoz; Dong-Jing Fu; Cynthia A Bossie; Larry Alphs
Journal:  Innov Clin Neurosci       Date:  2015 Nov-Dec

4.  The relation between childhood maltreatment and psychosis in patients with schizophrenia and non-psychiatric controls.

Authors:  Pamela DeRosse; George C Nitzburg; Bernie Kompancaril; Anil K Malhotra
Journal:  Schizophr Res       Date:  2014-04-03       Impact factor: 4.939

5.  Laterality in schizophrenia. A reaction time study.

Authors:  J Fishman; F Schwartz; E Bertuch; B Lesser; D Rescigno; B Viegener
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1991       Impact factor: 5.270

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.